Early Alert: Arrow International Removes Products with Spring Wire Guides
The US FDA has issued an early alert regarding a product removal initiated by Arrow International, a subsidiary of Teleflex Incorporated, concerning certain medical devices containing hydrophilic-coated Spring Wire Guide components.
According to the company, the hydrophilic coating may swell inconsistently when hydrated with saline, leading to clumping and potential detachment. This can release particles into the bloodstream and risk polymer emboli, which may cause adverse health consequences such as inflammation, thrombosis, ischemia, tissue injury, stroke, further intervention, or death.
Customers are advised to immediately check their inventory, cease use and distribution of the affected products, quarantine them, and contact Teleflex Customer Service for returns.
Key points
- Arrow International has recommended the removal of certain products containing Spring Wire Guide components.
- The hydrophilic coating on the guidewires may swell, clump, and detach when hydrated with saline.
- Detached particles can enter the bloodstream and cause emboli, leading to severe clinical risks.
- No serious injuries or deaths have been reported in association with this issue as of November 2026.
What it means for you
Clinicians and healthcare facilities should immediately inspect their inventories to identify, quarantine, and cease using any affected Arrow International products containing the specified spring wire guide components. Healthcare professionals in Pakistan should check with local suppliers or the Drug Regulatory Authority of Pakistan (DRAP) for any specific local alerts, availability notices, or recall guidance related to these Teleflex devices.
Early Alert: Arrow International Removes Products Containing Spring Wire Guide Components
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.